MedWellAI (MWAI) 주식 개요는 디지털 화폐 채굴에 관여합니다. 자세히 보기MWAI 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6위험 분석마이너스 주주 지분cash runway 경력이 1년 미만입니다.의미 있는 시가총액이 없습니다($3M)주식은 유동성이 매우 낮습니다+ 위험 1건 추가모든 위험 점검 보기MWAI Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.39535.6% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-32m7m2016201920222025202620282031Revenue US$304.5kEarnings US$36.7kAdvancedSet Fair ValueView all narrativesMedWellAI Inc. 경쟁사Windfall GeotekSymbol: OTCPK:WINK.FMarket cap: US$3.0mVocodia HoldingsSymbol: OTCPK:VHAIMarket cap: US$1.5mKindcardSymbol: OTCPK:KCRDMarket cap: US$3.6mArgo BlockchainSymbol: NasdaqCM:ARBKMarket cap: US$1.4m가격 이력 및 성과MedWellAI 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가US$0.3952주 최고가US$0.8052주 최저가US$0.21베타2.621개월 변동5.24%3개월 변동-9.92%1년 변동35.58%3년 변동-80.57%5년 변동-98.18%IPO 이후 변동-99.90%최근 뉴스 및 업데이트공시 • May 08MedWellAI Inc. Reconfirms Yearly Revenue GuidanceMedWellAI Inc. reconfirmed yearly revenue guidance of $2.3 million.공시 • Feb 19MedWellAI Inc. announced delayed 10-Q filingOn 02/18/2026, MedWellAI Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Feb 11MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC.MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC on February 10, 2026. In a related transaction MedWellAI signed a letter of intent to acquire Ageless Cosmetic Surgery Centers, Inc. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is within 60 days.공시 • Oct 02MedWellAI Inc. Auditor Raises 'Going Concern' DoubtMedWellAI Inc. filed its Annual on Sep 30, 2025 for the period ending Jun 30, 2025. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.공시 • Oct 01MedWellAI Inc. announced delayed annual 10-K filingOn 09/30/2025, MedWellAI Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Aug 19MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD to Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused on $24.46 Billion Corporate Wellness MarketMedWellAi Inc. confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and Wellness Telemedicine Platform, with main focus on corporate healthcare benefits market. Scheduled to go live in October, 2025, TeleMD is designed to deliver a comprehensive telehealth primary care that is affordable and accessible for everyone. Clients will be able to access all the healthcare care they need through TeleMd's platform and technology, easy-to-use desktop and mobile apps, resulting in getting timely healthcare advice, eliminating travel and wait time to schedule appointments. This platform will offer (1) affordable monthly subscription plans (retail + corporate clients) with unlimited access to the healthcare providers and certified telehealth therapists, (2) nationwide 365/24/7 access via smart device or desktop, (3) no co-pays, no cancelation or any other additional fees/charges. With innovative stack that includes Cloudflare, Google Font API, and Bootstrap, TeleMD is committed to leveraging technology for delivering healthcare services. BrighterMD solutions and their technology approach, provide an opportunity for TeleMD to offer their tech-savvy corporate clients with effective options on how to integrate the latest healthcare solutions into their current systems. TeleMD Ai is focused on two markets segments: Business-To-Public And Business-To-Business. Users will have access to unlimited appointments, 24 hours a day from the comfort of their home or office. B2B - Discounted Group Pricing for Companies: TeleMD delivers affordable healthcare for employees, while reducing premiums with high quality comprehensive telemedicine solution. Now, employers can offer extra benefits with primary care online, provide employees and their families with unlimited private appointments that will't be shared with insurers or employers. All employees can quickly and conveniently access team of medical professionals, as frequently as they need. TeleMD is a simple and effective addition to any benefits package. Enrolling employees into the program is available via API integration, or via EDI file transfer. Simple to set up, easy to use. Company's goal is to provide a seamless, robust and affordable healthcare solution for employers to offer their employees. By choosing TeleMD's telehealth services, employers will reduce insurance premiums, while offering convenient and extensive primary care and mental health support to employees that they can use whenever they need it. Additional services include: (1) Financial and Legal Consultations, (2) Life Coaching, (3) Medical Advocacy and (4) Nutritional Counseling. TeleMd's AI-enhanced platform will offer new ways to provide mental support and care. It will feature Ai Agent that can identify signs of depression or distress and provide on-the-go support, and connect individuals with human therapies when needed. 90% of chronic condition meds home delivered at a $0 copay. 125 acute meds at any pharmacy at a $0copay. TeleMD offers diabetes program at no added cost and OTC meds at a discount. Members save up to 80% on prescriptions; at most major RX retailers as well as 80% on any lab work at any Quest Diagnostics location. Bilingual Services: TeleMD differentiates itself by offering bilingual (English+ Spanish) Board-Certified doctors and mental health therapists. This FREE feature could be a valuable selling point for many corporations with diverse workforces that seek healthcare solutions that cater to employees with varying language needs, presenting a market niche to target. Currently FDA Registered with clinical trials completed. This platform l allows clients to take complete control of everyday health and wellness. Doctegrity is focused on providing (1) affordable telemedicine: cost-effective way for employers to provide healthcare benefits to their employees, including those who may not have traditional insurance coverage, (2) comprehensive solutions and care: their services include 365/24/7 access to board-certified physicians and licensed therapists for both physical and mental health needs and mental health therapists.더 많은 업데이트 보기Recent updates공시 • May 08MedWellAI Inc. Reconfirms Yearly Revenue GuidanceMedWellAI Inc. reconfirmed yearly revenue guidance of $2.3 million.공시 • Feb 19MedWellAI Inc. announced delayed 10-Q filingOn 02/18/2026, MedWellAI Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Feb 11MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC.MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC on February 10, 2026. In a related transaction MedWellAI signed a letter of intent to acquire Ageless Cosmetic Surgery Centers, Inc. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is within 60 days.공시 • Oct 02MedWellAI Inc. Auditor Raises 'Going Concern' DoubtMedWellAI Inc. filed its Annual on Sep 30, 2025 for the period ending Jun 30, 2025. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.공시 • Oct 01MedWellAI Inc. announced delayed annual 10-K filingOn 09/30/2025, MedWellAI Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Aug 19MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD to Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused on $24.46 Billion Corporate Wellness MarketMedWellAi Inc. confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and Wellness Telemedicine Platform, with main focus on corporate healthcare benefits market. Scheduled to go live in October, 2025, TeleMD is designed to deliver a comprehensive telehealth primary care that is affordable and accessible for everyone. Clients will be able to access all the healthcare care they need through TeleMd's platform and technology, easy-to-use desktop and mobile apps, resulting in getting timely healthcare advice, eliminating travel and wait time to schedule appointments. This platform will offer (1) affordable monthly subscription plans (retail + corporate clients) with unlimited access to the healthcare providers and certified telehealth therapists, (2) nationwide 365/24/7 access via smart device or desktop, (3) no co-pays, no cancelation or any other additional fees/charges. With innovative stack that includes Cloudflare, Google Font API, and Bootstrap, TeleMD is committed to leveraging technology for delivering healthcare services. BrighterMD solutions and their technology approach, provide an opportunity for TeleMD to offer their tech-savvy corporate clients with effective options on how to integrate the latest healthcare solutions into their current systems. TeleMD Ai is focused on two markets segments: Business-To-Public And Business-To-Business. Users will have access to unlimited appointments, 24 hours a day from the comfort of their home or office. B2B - Discounted Group Pricing for Companies: TeleMD delivers affordable healthcare for employees, while reducing premiums with high quality comprehensive telemedicine solution. Now, employers can offer extra benefits with primary care online, provide employees and their families with unlimited private appointments that will't be shared with insurers or employers. All employees can quickly and conveniently access team of medical professionals, as frequently as they need. TeleMD is a simple and effective addition to any benefits package. Enrolling employees into the program is available via API integration, or via EDI file transfer. Simple to set up, easy to use. Company's goal is to provide a seamless, robust and affordable healthcare solution for employers to offer their employees. By choosing TeleMD's telehealth services, employers will reduce insurance premiums, while offering convenient and extensive primary care and mental health support to employees that they can use whenever they need it. Additional services include: (1) Financial and Legal Consultations, (2) Life Coaching, (3) Medical Advocacy and (4) Nutritional Counseling. TeleMd's AI-enhanced platform will offer new ways to provide mental support and care. It will feature Ai Agent that can identify signs of depression or distress and provide on-the-go support, and connect individuals with human therapies when needed. 90% of chronic condition meds home delivered at a $0 copay. 125 acute meds at any pharmacy at a $0copay. TeleMD offers diabetes program at no added cost and OTC meds at a discount. Members save up to 80% on prescriptions; at most major RX retailers as well as 80% on any lab work at any Quest Diagnostics location. Bilingual Services: TeleMD differentiates itself by offering bilingual (English+ Spanish) Board-Certified doctors and mental health therapists. This FREE feature could be a valuable selling point for many corporations with diverse workforces that seek healthcare solutions that cater to employees with varying language needs, presenting a market niche to target. Currently FDA Registered with clinical trials completed. This platform l allows clients to take complete control of everyday health and wellness. Doctegrity is focused on providing (1) affordable telemedicine: cost-effective way for employers to provide healthcare benefits to their employees, including those who may not have traditional insurance coverage, (2) comprehensive solutions and care: their services include 365/24/7 access to board-certified physicians and licensed therapists for both physical and mental health needs and mental health therapists.공시 • May 16Integrated Ventures, Inc. announced delayed 10-Q filingOn 05/15/2025, Integrated Ventures, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Nov 16Integrated Ventures, Inc. announced delayed 10-Q filingOn 11/15/2024, Integrated Ventures, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Sep 30Integrated Ventures, Inc. Auditor Raises 'Going Concern' DoubtIntegrated Ventures, Inc. filed its 10-K on Sep 28, 2022 for the period ending Jun 30, 2022. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.공시 • May 15Integrated Ventures, Inc. Provides Revenue Guidance for the Full Year 2021Integrated Ventures, Inc. provided revenue guidance for the full year 2021. For the year, total revenues for 2021 are projected to be in $2.3 million to $2.4 million range with a 60%+ gross margin.공시 • Jan 24Integrated Ventures, Inc. announced that it expects to receive $3 million in funding from BHP Capital NY, Inc.Integrated Ventures, Inc. (OTCPK:INTV) announced that it has executed a binding term sheet for a private placement of convertible preferred series C stock led by returning investor BHP Capital NY, Inc. for gross proceeds of $3 million on January 22, 2021. The transaction will be completed in tranches and the company expects to receive an initial tranche in next few days. The investor has received a right to convert newly registered preferred stock into common shares at a fixed conversion price of $0.068.공시 • Sep 22Integrated Ventures, Inc. announced that it expects to receive $1 million in funding from Eagle Equities, LLCIntegrated Ventures, Inc. (OTCPK:INTV)announced that it has entered into a securities purchase agreement with Eagle Equities, LLC for private placement of a 6% convertible redeemable note due February 4, 2022 for gross proceeds of $1,000,000 on August 4, 2020. The note will carry a fixed interest coupon of 6% per annum, issued at a discount of 8% and will mature on February 4, 2022. The note provides the holder the right to convert the note into shares of the company’s common stock at a price for each share of common stock equal to the lower of 70% of market price as reported on the National Quotations Bureau OTC Market exchange which the company’s shares are traded or any exchange upon which the common stock may be traded in the future, for the fifteen prior trading days including the day upon which a notice of Conversion is received by the company. The company will receive funding in tranches, $250,000 in its first and second tranche. The company shall not consummate the sale of any convertible securities until the earlier of 30 days after purchase of the second tranche or, if the second tranche is not funded, then 60 days after the closing date of the first tranche. The company will pay $6,000 as legal fees in its first and second tranche. The company issued the note pursuant to exemption provided under Regulation D. On the same day, the company has received its first tranche of $250,000.주주 수익률MWAIUS SoftwareUS 시장7D2.1%1.1%-0.9%1Y35.6%-8.9%24.4%전체 주주 수익률 보기수익률 대 산업: MWAI은 지난 1년 동안 -8.9%의 수익을 기록한 US Software 산업보다 더 좋은 성과를 냈습니다.수익률 대 시장: MWAI은 지난 1년 동안 24.4%를 기록한 US 시장보다 더 좋은 성과를 냈습니다.주가 변동성Is MWAI's price volatile compared to industry and market?MWAI volatilityMWAI Average Weekly Movementn/aSoftware Industry Average Movement9.6%Market Average Movement7.2%10% most volatile stocks in US Market16.2%10% least volatile stocks in US Market3.1%안정적인 주가: MWAI의 주가는 지난 3개월 동안 US 시장보다 변동성이 컸습니다.시간에 따른 변동성: Insufficient data to determine MWAI의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/a1Steve Rubakhwww.medwellai.com는 디지털 화폐 채굴에 종사하고 있습니다. 이 회사는 채굴 장비와 채굴 장비를 제조 및 판매합니다. 이 회사는 펜실베이니아주 티오가에 본사를 두고 있습니다.더 보기MedWellAI Inc. 기초 지표 요약MedWellAI의 순이익과 매출은 시가총액과 어떻게 비교됩니까?MWAI 기초 통계시가총액US$2.53m순이익 (TTM)-US$2.39m매출 (TTM)US$1.86m1.4x주가매출비율(P/S)-1.1x주가수익비율(P/E)MWAI는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표MWAI 손익계산서 (TTM)매출US$1.86m매출원가US$1.28m총이익US$582.41k기타 비용US$2.97m순이익-US$2.39m최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)-0.37총이익률31.25%순이익률-128.32%부채/자본 비율-6.6%MWAI의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/16 14:46종가2026/05/12 00:00수익2026/03/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스MedWellAI Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 08MedWellAI Inc. Reconfirms Yearly Revenue GuidanceMedWellAI Inc. reconfirmed yearly revenue guidance of $2.3 million.
공시 • Feb 19MedWellAI Inc. announced delayed 10-Q filingOn 02/18/2026, MedWellAI Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Feb 11MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC.MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC on February 10, 2026. In a related transaction MedWellAI signed a letter of intent to acquire Ageless Cosmetic Surgery Centers, Inc. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is within 60 days.
공시 • Oct 02MedWellAI Inc. Auditor Raises 'Going Concern' DoubtMedWellAI Inc. filed its Annual on Sep 30, 2025 for the period ending Jun 30, 2025. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
공시 • Oct 01MedWellAI Inc. announced delayed annual 10-K filingOn 09/30/2025, MedWellAI Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Aug 19MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD to Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused on $24.46 Billion Corporate Wellness MarketMedWellAi Inc. confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and Wellness Telemedicine Platform, with main focus on corporate healthcare benefits market. Scheduled to go live in October, 2025, TeleMD is designed to deliver a comprehensive telehealth primary care that is affordable and accessible for everyone. Clients will be able to access all the healthcare care they need through TeleMd's platform and technology, easy-to-use desktop and mobile apps, resulting in getting timely healthcare advice, eliminating travel and wait time to schedule appointments. This platform will offer (1) affordable monthly subscription plans (retail + corporate clients) with unlimited access to the healthcare providers and certified telehealth therapists, (2) nationwide 365/24/7 access via smart device or desktop, (3) no co-pays, no cancelation or any other additional fees/charges. With innovative stack that includes Cloudflare, Google Font API, and Bootstrap, TeleMD is committed to leveraging technology for delivering healthcare services. BrighterMD solutions and their technology approach, provide an opportunity for TeleMD to offer their tech-savvy corporate clients with effective options on how to integrate the latest healthcare solutions into their current systems. TeleMD Ai is focused on two markets segments: Business-To-Public And Business-To-Business. Users will have access to unlimited appointments, 24 hours a day from the comfort of their home or office. B2B - Discounted Group Pricing for Companies: TeleMD delivers affordable healthcare for employees, while reducing premiums with high quality comprehensive telemedicine solution. Now, employers can offer extra benefits with primary care online, provide employees and their families with unlimited private appointments that will't be shared with insurers or employers. All employees can quickly and conveniently access team of medical professionals, as frequently as they need. TeleMD is a simple and effective addition to any benefits package. Enrolling employees into the program is available via API integration, or via EDI file transfer. Simple to set up, easy to use. Company's goal is to provide a seamless, robust and affordable healthcare solution for employers to offer their employees. By choosing TeleMD's telehealth services, employers will reduce insurance premiums, while offering convenient and extensive primary care and mental health support to employees that they can use whenever they need it. Additional services include: (1) Financial and Legal Consultations, (2) Life Coaching, (3) Medical Advocacy and (4) Nutritional Counseling. TeleMd's AI-enhanced platform will offer new ways to provide mental support and care. It will feature Ai Agent that can identify signs of depression or distress and provide on-the-go support, and connect individuals with human therapies when needed. 90% of chronic condition meds home delivered at a $0 copay. 125 acute meds at any pharmacy at a $0copay. TeleMD offers diabetes program at no added cost and OTC meds at a discount. Members save up to 80% on prescriptions; at most major RX retailers as well as 80% on any lab work at any Quest Diagnostics location. Bilingual Services: TeleMD differentiates itself by offering bilingual (English+ Spanish) Board-Certified doctors and mental health therapists. This FREE feature could be a valuable selling point for many corporations with diverse workforces that seek healthcare solutions that cater to employees with varying language needs, presenting a market niche to target. Currently FDA Registered with clinical trials completed. This platform l allows clients to take complete control of everyday health and wellness. Doctegrity is focused on providing (1) affordable telemedicine: cost-effective way for employers to provide healthcare benefits to their employees, including those who may not have traditional insurance coverage, (2) comprehensive solutions and care: their services include 365/24/7 access to board-certified physicians and licensed therapists for both physical and mental health needs and mental health therapists.
공시 • May 08MedWellAI Inc. Reconfirms Yearly Revenue GuidanceMedWellAI Inc. reconfirmed yearly revenue guidance of $2.3 million.
공시 • Feb 19MedWellAI Inc. announced delayed 10-Q filingOn 02/18/2026, MedWellAI Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Feb 11MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC.MedWellAI Inc. (OTCPK:MWAI) signed a letter of intent to acquire Resonate Blends, Inc. (OTCPK:KOAN) from FirstFire Capital Management LLC on February 10, 2026. In a related transaction MedWellAI signed a letter of intent to acquire Ageless Cosmetic Surgery Centers, Inc. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is within 60 days.
공시 • Oct 02MedWellAI Inc. Auditor Raises 'Going Concern' DoubtMedWellAI Inc. filed its Annual on Sep 30, 2025 for the period ending Jun 30, 2025. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
공시 • Oct 01MedWellAI Inc. announced delayed annual 10-K filingOn 09/30/2025, MedWellAI Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Aug 19MedWellAi, Inc Joins Trump Mobile In Engaging BrighterMD to Develop Ai-Inhanced Healthcare Telemedicine Platform, Focused on $24.46 Billion Corporate Wellness MarketMedWellAi Inc. confirm the collaboration and execution of Software Development Agreement with BrighterMD, to develop and launch Company's latest initiative: TeleMD.Ai - Nationwide B2B and B2C Healthcare and Wellness Telemedicine Platform, with main focus on corporate healthcare benefits market. Scheduled to go live in October, 2025, TeleMD is designed to deliver a comprehensive telehealth primary care that is affordable and accessible for everyone. Clients will be able to access all the healthcare care they need through TeleMd's platform and technology, easy-to-use desktop and mobile apps, resulting in getting timely healthcare advice, eliminating travel and wait time to schedule appointments. This platform will offer (1) affordable monthly subscription plans (retail + corporate clients) with unlimited access to the healthcare providers and certified telehealth therapists, (2) nationwide 365/24/7 access via smart device or desktop, (3) no co-pays, no cancelation or any other additional fees/charges. With innovative stack that includes Cloudflare, Google Font API, and Bootstrap, TeleMD is committed to leveraging technology for delivering healthcare services. BrighterMD solutions and their technology approach, provide an opportunity for TeleMD to offer their tech-savvy corporate clients with effective options on how to integrate the latest healthcare solutions into their current systems. TeleMD Ai is focused on two markets segments: Business-To-Public And Business-To-Business. Users will have access to unlimited appointments, 24 hours a day from the comfort of their home or office. B2B - Discounted Group Pricing for Companies: TeleMD delivers affordable healthcare for employees, while reducing premiums with high quality comprehensive telemedicine solution. Now, employers can offer extra benefits with primary care online, provide employees and their families with unlimited private appointments that will't be shared with insurers or employers. All employees can quickly and conveniently access team of medical professionals, as frequently as they need. TeleMD is a simple and effective addition to any benefits package. Enrolling employees into the program is available via API integration, or via EDI file transfer. Simple to set up, easy to use. Company's goal is to provide a seamless, robust and affordable healthcare solution for employers to offer their employees. By choosing TeleMD's telehealth services, employers will reduce insurance premiums, while offering convenient and extensive primary care and mental health support to employees that they can use whenever they need it. Additional services include: (1) Financial and Legal Consultations, (2) Life Coaching, (3) Medical Advocacy and (4) Nutritional Counseling. TeleMd's AI-enhanced platform will offer new ways to provide mental support and care. It will feature Ai Agent that can identify signs of depression or distress and provide on-the-go support, and connect individuals with human therapies when needed. 90% of chronic condition meds home delivered at a $0 copay. 125 acute meds at any pharmacy at a $0copay. TeleMD offers diabetes program at no added cost and OTC meds at a discount. Members save up to 80% on prescriptions; at most major RX retailers as well as 80% on any lab work at any Quest Diagnostics location. Bilingual Services: TeleMD differentiates itself by offering bilingual (English+ Spanish) Board-Certified doctors and mental health therapists. This FREE feature could be a valuable selling point for many corporations with diverse workforces that seek healthcare solutions that cater to employees with varying language needs, presenting a market niche to target. Currently FDA Registered with clinical trials completed. This platform l allows clients to take complete control of everyday health and wellness. Doctegrity is focused on providing (1) affordable telemedicine: cost-effective way for employers to provide healthcare benefits to their employees, including those who may not have traditional insurance coverage, (2) comprehensive solutions and care: their services include 365/24/7 access to board-certified physicians and licensed therapists for both physical and mental health needs and mental health therapists.
공시 • May 16Integrated Ventures, Inc. announced delayed 10-Q filingOn 05/15/2025, Integrated Ventures, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Nov 16Integrated Ventures, Inc. announced delayed 10-Q filingOn 11/15/2024, Integrated Ventures, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Sep 30Integrated Ventures, Inc. Auditor Raises 'Going Concern' DoubtIntegrated Ventures, Inc. filed its 10-K on Sep 28, 2022 for the period ending Jun 30, 2022. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
공시 • May 15Integrated Ventures, Inc. Provides Revenue Guidance for the Full Year 2021Integrated Ventures, Inc. provided revenue guidance for the full year 2021. For the year, total revenues for 2021 are projected to be in $2.3 million to $2.4 million range with a 60%+ gross margin.
공시 • Jan 24Integrated Ventures, Inc. announced that it expects to receive $3 million in funding from BHP Capital NY, Inc.Integrated Ventures, Inc. (OTCPK:INTV) announced that it has executed a binding term sheet for a private placement of convertible preferred series C stock led by returning investor BHP Capital NY, Inc. for gross proceeds of $3 million on January 22, 2021. The transaction will be completed in tranches and the company expects to receive an initial tranche in next few days. The investor has received a right to convert newly registered preferred stock into common shares at a fixed conversion price of $0.068.
공시 • Sep 22Integrated Ventures, Inc. announced that it expects to receive $1 million in funding from Eagle Equities, LLCIntegrated Ventures, Inc. (OTCPK:INTV)announced that it has entered into a securities purchase agreement with Eagle Equities, LLC for private placement of a 6% convertible redeemable note due February 4, 2022 for gross proceeds of $1,000,000 on August 4, 2020. The note will carry a fixed interest coupon of 6% per annum, issued at a discount of 8% and will mature on February 4, 2022. The note provides the holder the right to convert the note into shares of the company’s common stock at a price for each share of common stock equal to the lower of 70% of market price as reported on the National Quotations Bureau OTC Market exchange which the company’s shares are traded or any exchange upon which the common stock may be traded in the future, for the fifteen prior trading days including the day upon which a notice of Conversion is received by the company. The company will receive funding in tranches, $250,000 in its first and second tranche. The company shall not consummate the sale of any convertible securities until the earlier of 30 days after purchase of the second tranche or, if the second tranche is not funded, then 60 days after the closing date of the first tranche. The company will pay $6,000 as legal fees in its first and second tranche. The company issued the note pursuant to exemption provided under Regulation D. On the same day, the company has received its first tranche of $250,000.
